ambroxol drug breaks phlegm used treatment respiratory diseases associated viscid excessive mucus ambroxol often administered active ingredient cough syrup patented came medical use ambroxol indicated secretolytic therapy bronchopulmonary diseases associated abnormal mucus secretion impaired mucus transport promotes mucus clearance facilitates expectoration eases productive cough allowing patients breathe freely many different formulations developed since first marketing authorisation ambroxol available syrup tablets pastilles dry powder sachets inhalation solution drops ampules well effervescent tablets ambroxol also provides pain relief acute sore throat pain sore throat hallmark acute sore throat usually caused viral infection infection self limited patient recovers normally days bothering patient continuous pain throat maximized patient swallowing main goal treatment thus reduce pain main property ambroxol treating sore throat local anaesthetic effect described first late explained confirmed recent work field tests date uncovered specific contraindications ambroxol however caution suggested patients gastric ulceration usage first trimester pregnancy substance acts mucus membranes restoring physiological clearance mechanisms respiratory tract play important role bodys natural defence mechanisms several mechanisms including breaking phlegm stimulating mucus production stimulating synthesis release surfactant type ii surfactant acts antiglue factor reducing adhesion mucus bronchial wall improving transport providing protection infection irritating ambroxol potent inhibitor neuronal na property led development lozenge containing mg ambroxol many stateoftheart clinical demonstrated efficacy ambroxol relieving pain acute sore throat rapid onset action effect lasting least three hours ambroxol also antiinflammatory reducing redness sore throat ambroxol recently shown increase activity lysosomal enzyme glucocerebrosidase may useful therapeutic agent gaucher disease parkinsons also recently shown ambroxol triggers exocytosis lysosomes releasing calcium acidic cellular calcium stores occurs diffusion ambroxol lysosomes lysosomal ph mechanism likely responsible mucolytic effects drug may also explain reported activity gaucher parkinsons disease ambroxol parent drug bromhexine shown induce autophagy several cell types ambroxol shown potentiate rifampicin therapy model tuberculosis host directed ambroxol also enhances lung levels wide range active ingredient muciclar italy mucosolvan mucobrox spain bisolvon switzerland cloxan mexico mucol lasolvan mucoangin surbronc brontex lithuanian ambro kazakhstan ambolar lysopain currently registered use httpsenwikipediaorgwikiambroxol